Application Information

This drug has been submitted to the FDA under the reference 207103/001.

Names and composition

"IBRANCE" is the commercial name of a drug composed of PALBOCICLIB.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
207103/001 IBRANCE PALBOCICLIB CAPSULE/ORAL 75MG
207103/002 IBRANCE PALBOCICLIB CAPSULE/ORAL 100MG
207103/003 IBRANCE PALBOCICLIB CAPSULE/ORAL 125MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
207103/001 IBRANCE PALBOCICLIB CAPSULE/ORAL 75MG
207103/002 IBRANCE PALBOCICLIB CAPSULE/ORAL 100MG
207103/003 IBRANCE PALBOCICLIB CAPSULE/ORAL 125MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved